230 related articles for article (PubMed ID: 26087615)
1. [Role of bone-density-conserving agents in the treatment for pain in patients with bone metastases].
Zhabina AS; Semiglazova TY
Vopr Onkol; 2015; 61(2):303-10. PubMed ID: 26087615
[TBL] [Abstract][Full Text] [Related]
2. Evidence on the analgesic role of bisphosphonates and denosumab in the treatment of pain due to bone metastases: A systematic review within the European Association for Palliative Care guidelines project.
Porta-Sales J; Garzón-Rodríguez C; Llorens-Torromé S; Brunelli C; Pigni A; Caraceni A
Palliat Med; 2017 Jan; 31(1):5-25. PubMed ID: 27006430
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates for malignancy-related bone disease: current status, future developments.
Body JJ
Support Care Cancer; 2006 May; 14(5):408-18. PubMed ID: 16450087
[TBL] [Abstract][Full Text] [Related]
4. The cost of treatment of skeletal-related events in patients with bone metastases from lung cancer.
Delea T; Langer C; McKiernan J; Liss M; Edelsberg J; Brandman J; Sung J; Raut M; Oster G
Oncology; 2004; 67(5-6):390-6. PubMed ID: 15713995
[TBL] [Abstract][Full Text] [Related]
5. Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain.
von Moos R; Costa L; Ripamonti CI; Niepel D; Santini D
Eur J Cancer; 2017 Jan; 71():80-94. PubMed ID: 27984770
[TBL] [Abstract][Full Text] [Related]
6. Metastatic bone disease in the era of bone-targeted therapy: clinical impact.
Ibrahim T; Farolfi A; Mercatali L; Ricci M; Amadori D
Tumori; 2013; 99(1):1-9. PubMed ID: 23548992
[TBL] [Abstract][Full Text] [Related]
7. Bisphosphonates: reducing the risk of skeletal complications from bone metastasis.
Costa L
Breast; 2007 Dec; 16 Suppl 3():S16-20. PubMed ID: 18032044
[TBL] [Abstract][Full Text] [Related]
8. Treatment of metastatic bone disease in breast cancer: bisphosphonates.
Diel IJ; Solomayer EF; Bastert G
Clin Breast Cancer; 2000 Apr; 1(1):43-51. PubMed ID: 11899389
[TBL] [Abstract][Full Text] [Related]
9. Treatment options for breast cancer and bone metastases.
Pecherstorfer M
Womens Health (Lond); 2009 Mar; 5(2):149-63. PubMed ID: 19245353
[TBL] [Abstract][Full Text] [Related]
10. Current use of bisphosphonates in oncology. International Bone and Cancer Study Group.
Body JJ; Bartl R; Burckhardt P; Delmas PD; Diel IJ; Fleisch H; Kanis JA; Kyle RA; Mundy GR; Paterson AH; Rubens RD
J Clin Oncol; 1998 Dec; 16(12):3890-9. PubMed ID: 9850035
[TBL] [Abstract][Full Text] [Related]
11. Optimal management of metastatic bone disease.
Major P
Eur J Oncol Nurs; 2007; 11 Suppl 2():S32-7. PubMed ID: 17804294
[TBL] [Abstract][Full Text] [Related]
12. Managing metastatic bone pain: the role of bisphosphonates.
Gralow J; Tripathy D
J Pain Symptom Manage; 2007 Apr; 33(4):462-72. PubMed ID: 17397707
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of bone metastases with bisphosphonates].
Gremaud M; Delouche D; Monnerat C
Rev Med Suisse; 2006 Aug; 2(75):1861-6. PubMed ID: 16948423
[TBL] [Abstract][Full Text] [Related]
14. Pain outcomes in patients with bone metastases from advanced cancer: assessment and management with bone-targeting agents.
Patrick DL; Cleeland CS; von Moos R; Fallowfield L; Wei R; Öhrling K; Qian Y
Support Care Cancer; 2015 Apr; 23(4):1157-68. PubMed ID: 25533578
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of intravenous ibandronate and pamindronate in patients with bone metastases from breast or lung cancer: effect on metastatic bone pain.
Heras P; Hatzopoulos A; Heras V; Kritikos N; Karagiannis S; Kritikos K
Am J Ther; 2011 Sep; 18(5):340-2. PubMed ID: 20634675
[TBL] [Abstract][Full Text] [Related]
16. Approaches to managing bone metastases from breast cancer: the role of bisphosphonates.
Mystakidou K; Katsouda E; Stathopoulou E; Vlahos L
Cancer Treat Rev; 2005 Jun; 31(4):303-11. PubMed ID: 16039956
[TBL] [Abstract][Full Text] [Related]
17. [Bone metastases in lung cancer].
Tsuya A; Fukuoka M
Clin Calcium; 2008 Apr; 18(4):455-9. PubMed ID: 18379026
[TBL] [Abstract][Full Text] [Related]
18. [Clinical implications of bisphosphonate for bone metastases of prostate cancer].
Kitagawa Y; Konaka H; Mizokami A; Namiki M
Nihon Rinsho; 2007 Nov; 65 Suppl 9():356-9. PubMed ID: 18161131
[No Abstract] [Full Text] [Related]
19. [Bisphosphonate treatment against breast cancer with bone metastases].
Kohno N
Nihon Rinsho; 2007 Jun; 65 Suppl 6():575-81. PubMed ID: 17682213
[No Abstract] [Full Text] [Related]
20. [Bisphosphonates in oncology].
Kurth AA; Heidenreich A; Diel I
Orthopade; 2007 Feb; 36(2):131-5. PubMed ID: 17252255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
